Journal for ImmunoTherapy of Cancer (Nov 2020)

430 A phase II study of nivolumab + BMS-986016 (relatlimab) in patients with metastatic uveal melanoma(UM) (CA224–094)

  • Jose Lutzky,
  • Lynn Feun,
  • William Harbour

DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0430
Journal volume & issue
Vol. 8, no. Suppl 3

Abstract

Read online

No abstracts available.